新日本製薬株式会社 · Chemicals · FY ends Sep
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Eijiro Yamada | 4,101,500 | 19.40% | ¥9.4B | ¥213M |
| 2 | Lapris Co., Ltd. | 2,980,600 | 14.10% | ¥6.8B | ¥155M |
| 3 | Megumi Yamada | 2,929,000 | 13.85% | ¥6.7B | ¥152M |
| 4 | 公益財団法人新日本先進医療研究財団 | 1,739,200 | 8.22% | ¥4.0B | ¥90.4M |
| 5 | 日本マスタートラスト信託銀行株式会社 | 1,072,100 | 5.07% | ¥2.5B | ¥55.7M |
| 6 | Takahiro Goto | 847,999 | 4.01% | ¥1.9B | ¥44.1M |
| 7 | STATE STREET BANK AND TRUST COMPANY 510355 | 120,500 | 0.57% | ¥276M | ¥6.3M |
| 8 | Sagawa Printing Co., Ltd. | 116,000 | 0.55% | ¥266M | ¥6.0M |
| 9 | 株式会社日本カストディ銀行 | 115,000 | 0.54% | ¥263M | ¥6.0M |
| 10 | 新日本製薬社員持株会 | 114,000 | 0.54% | ¥261M | ¥5.9M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Takahiro Goto | President & Representative Director, CEO | 847,999 | ¥1.9B | — |
| 福原 光佳 | Senior Managing Director, COO | 85,351 | ¥195M | — |
| 安田 幸代 | Director | — | — | — |
| 南谷 朝子 | Director | — | — | — |
| 善明 啓一 | Director | — | — | — |
| 田邊 俊 | Director | 11,000 | ¥25.2M | — |
| 中西 裕二 | Director | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Sep 2025 | ¥2,289 | ¥120.48 | 19.0x | ¥52.0 | 21,855,200 |
| FY ending Sep 2024 | ¥1,712 | ¥129.69 | 13.2x | ¥45.0 | 21,855,200 |
| FY ending Sep 2023 | ¥1,526 | ¥111.37 | 13.7x | ¥33.0 | 21,855,200 |
| FY ending Sep 2022 | ¥1,506 | ¥109.91 | 13.7x | ¥33.0 | 21,855,200 |